海欣股份: 上海海欣集团股份有限公司关于转让上海海欣医药股份有限公司股权的进展公告

Core Viewpoint - Shanghai Haixin Group Co., Ltd. has successfully completed the transfer of 51.3249% equity in Shanghai Haixin Pharmaceutical Co., Ltd. to Chongqing Huisheng Yunjian Business Information Consulting Center for a total amount of 23.0494 million yuan [2][3]. Transaction Overview - Haixin Asset Management Co., Ltd., a wholly-owned subsidiary of Shanghai Haixin Group, transferred its 51.3249% stake in Haixin Pharmaceutical for 23.0494 million yuan to Huisheng Yunjian [3]. - The transfer agreement included three payment phases, with the third payment of 1.1525 million yuan recently received, completing the total payment [2][3]. - As of the announcement date, Haixin Asset has received a total of 23.0494 million yuan from Huisheng Yunjian, fulfilling the payment obligations under the transfer agreement [2].